Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
Atara Biotherapeutics (ATRA) Stock Price & Analysis
1,041 Followers
ATRA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $3.08
Previous Close$0.71
Volume1.19M
Average Volume (3M)2.85M
Market Cap
$84.51M
Enterprise Value$30.61M
Total Cash (Recent Filing)$102.41M
Total Debt (Recent Filing)$48.51M
Price to Earnings (P/E)-0.3
Beta2.50
Next Earnings
May 08, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.61
Shares Outstanding119,359,230
10 Day Avg. Volume1,115,342
30 Day Avg. Volume2,846,572
Standard Deviation0.26
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.66
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.89
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.11
Forecast
1Y Price Target
$5.43Price Target Upside666.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Atara Biotherapeutics News
PremiumCompany Announcements
Atara Biotherapeutics Board Member Decides Not to Seek Re-Election
PremiumCompany Announcements
Atara Biotherapeutics Restructures, CMO Transitions to Consultant
Ownership Overview
10.83% Insiders
20.05% Mutual Funds
26.72% Other Institutional Investors
42.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATRA FAQ
What was Atara Biotherapeutics’s price range in the past 12 months?
Atara Biotherapeutics lowest stock price was $0.20 and its highest was $3.08 in the past 12 months.
What is Atara Biotherapeutics’s market cap?
Currently, no data Available
When is Atara Biotherapeutics’s upcoming earnings report date?
Atara Biotherapeutics’s upcoming earnings report date is May 08, 2024 which is in 22 days.
How were Atara Biotherapeutics’s earnings last quarter?
Atara Biotherapeutics released its earnings results on Mar 28, 2024. The company reported -$0.56 earnings per share for the quarter, missing the consensus estimate of -$0.445 by -$0.115.
Is Atara Biotherapeutics overvalued?
According to Wall Street analysts Atara Biotherapeutics’s price is currently Undervalued.
Does Atara Biotherapeutics pay dividends?
Atara Biotherapeutics does not currently pay dividends.
What is Atara Biotherapeutics’s EPS estimate?
Atara Biotherapeutics’s EPS estimate is -$0.23.
How many shares outstanding does Atara Biotherapeutics have?
Atara Biotherapeutics has 119,359,230 shares outstanding.
What happened to Atara Biotherapeutics’s price movement after its last earnings report?
Atara Biotherapeutics reported an EPS of -$0.56 in its last earnings report, missing expectations of -$0.445. Following the earnings report the stock price went down -1.429%.
Which hedge fund is a major shareholder of Atara Biotherapeutics?
Among the largest hedge funds holding Atara Biotherapeutics’s share is Wexford Capital LP. It holds Atara Biotherapeutics’s shares valued at 15K.
---
Atara Biotherapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.43 (666.95% Upside)
$5.43 (666.95% Upside)
Blogger Sentiment
Bullish
ATRA Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 16.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $40.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 6.2%
Last 30 Days ▼ 6.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.00%
12-Months-Change
Fundamentals
Return on Equity
-2014.86%
Trailing 12-Months
Asset Growth
-56.03%
Trailing 12-Months
Company Description
Atara Biotherapeutics
Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.
---
ATRA Earnings Call
Q3 2023
0:00 / 0:00
---
ATRA Stock 12 Months Forecast
Average Price Target
$5.43
▲(666.95% Upside)
Best Analysts Covering ATRA
1 Year
1 Year Success Rate
21/40 ratings generated profit
1 Year Average Return
+20.99%
reiterated a buy rating 20 days ago
Copying John Newman's trades and holding each position for 1 Year would result in 52.50% of your transactions generating a profit, with an average return of +20.99% per trade.
---